Efficacy and Safety of Pulmonary Arterial Hypertension-specific Therapy in Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of Pulmonary Arterial Hypertension-specific Therapy in Pulmonary Arterial Hypertension

Published:2016-08 Issue:2 Volume:150 Page:353-366
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Liu Huan-long,Chen Xue-yan,Li Jie-ru,Su Su-wen,Ding Tao,Shi Chen-xia,Jiang Yun-fa,Zhu Zhong-ning

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference48 articles.

1. Current treatment approaches to pulmonary arterial hypertension;Provencher;Can J Cardiol,2015

2. An update on the management of pulmonary arterial hypertension and the pharmacist’s role;Macaulay;J Pharm Pract,2016

3. Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report;Taichman;Chest,2014

4. Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial;Tapson;Chest,2013

5. Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses;Galiè;Eur Heart J,2010

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver injury associated with endothelin receptor antagonists: a pharmacovigilance study based on FDA adverse event reporting system data;International Journal of Clinical Pharmacy;2024-06-20

2. Efficacy of inhaled iloprost in children with pulmonary hypertension after pediatric cardiac surgery: a case series;The Cardiothoracic Surgeon;2024-04-09

3. Treatment of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review and meta-analysis;Internal and Emergency Medicine;2024-02-20

4. Liver injury associated with endothelin receptor antagonists: a pharmacovigilance study based on FDA adverse event reporting system data;2024-02-20

5. A Network Meta-analysis of the Efficacy and Safety of Targeted Drug Combinations in the Treatment of Pulmonary Arterial Hypertension;Cardiology Discovery;2023-11-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3